Lindsey Cass

1.5k citations

37 papers · 1.0k indexed · h-index 18

Epidemiology top 5%
- Respiratory viral infections research 11
- Influenza Virus Research Studies 4
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 6
- Antifungal resistance and susceptibility 5
Physiology top 10%
- Asthma and respiratory diseases 6
Modeling and Simulation top 10%
Immunology
Virology
- HIV Research and Treatment 5
Insect Science
- Insect-Plant Interactions and Control 5
Molecular Biology
- Biochemical and Molecular Research 4

Co-authors: Alan Bye Constantin Efthymiopoulos Amy Peng Frederick G. Hayden David P. Calfee D. G. Harcourt Richard Fritz W. Gregory Alvord
Cited by: Epidemiology Infectious Diseases Physiology
Journals: Nature (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)The Journal of Infectious Diseases (3 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Lindsey Cass

34 papers receiving 967 citations

Peers

Countries citing papers authored by Lindsey Cass

Since Specialization

Citations

This map shows the geographic impact of Lindsey Cass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsey Cass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsey Cass more than expected).

Fields of papers citing papers by Lindsey Cass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsey Cass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsey Cass. The network helps show where Lindsey Cass may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lindsey Cass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lindsey Cass Line = papers co-authored together Lindsey Cass links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	In vitro and clinical data demonstrate negligible risk of drug–drug interactions with opelconazole, a novel inhaled antifungal agent Journal of Antimicrobial Chemotherapy ·Lindsey Cass,John Ayrton,Roger J. M. Brüggemann,Jerome A. Moore,Ubaldo J. Martin,Laura Grey,Michele Hyman,Lance Berman	2025	2
2	A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge Infectious Diseases and Therapy ·Geoff Kitson,Martin C. Byford,Lindsey Cass,D. Howat,Brigitte Köhn,Alessandra Bisquera,Andrew Catchpole,Nicolas Noulin,Douglas Thomson	2025	0
3	PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections Journal of Fungi ·Alison D. Murray,Lindsey Cass,Kazuhiro Ito,Nicole Pagani,Darius Armstrong‐James,Paras Dalal,Anna Reed,Pete Strong	2020	31
4	Reduced Nasal Viral Load and IFN Responses in Infants with Respiratory Syncytial Virus Bronchiolitis and Respiratory Failure American Journal of Respiratory and Critical Care Medicine ·Ryan S. Thwaites,Matthew Coates,Kazuhiro Ito,Marwa Ghazaly,Calandra Feather,Farhana Abdulla,Tanushree Tunstall,Pooja Jain,Lindsey Cass,Garth Rapeport,Trevor T. Hansel,Simon Nadel,Peter Openshaw	2018	72
5	1335. Safety and Pharmacokinetic Profile of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-protein Polymerase, in a Single and Multiple-Ascending Dose Study in Healthy Volunteer and Mild Asthmatics Open Forum Infectious Diseases ·Lindsey Cass,Amanda Davis,Alison D. Murray,Kathy Woodward,Kazuhiro Ito,Pete Strong,Garth Rapeport	2018	6
6	Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis The Journal of Infectious Diseases ·Ryan S. Thwaites,Kazuhiro Ito,Jasmine M. S. Chingono,Matthew Coates,Hannah C. Jarvis,Tanushree Tunstall,Lauren Anderson-Dring,Lindsey Cass,Garth Rapeport,Peter Openshaw,Simon Nadel,Trevor T. Hansel	2017	27
7	Safety, pharmacokinetic and pharmacodynamic profile of RV568, a narrow spectrum kinase inhibitor, following repeat inhaled dosing in COPD patients European Respiratory Journal ·Paul Russell,Lindsey Cass,Kazuhiro Ito,Catherine E. Charron,Pete Strong,Garth Rapeport,Dave Singh	2013	4
8	RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus European Respiratory Journal ·Lindsey Cass,Kazuhiro Ito,Catherine E. Charron,Pete Strong,Chantelle Norton,Anthony Gilbert,Rob Lambkin‐Williams,Alex Mann,Garth Rapeport	2013	3
9	Pharmacokinetics and Tolerability of GW420867X, a Nonnucleoside Reverse Transcriptase Inhibitor, following Single Escalating Doses in Healthy Male Volunteers The Journal of Clinical Pharmacology ·Katy H. P. Moore,Lindsey Cass,Nigel Dallow,Timothy C. Hardman,Anne E. Jones,Malcolm Boyce,William Prince	2001	1
10	The Bioavailability of the Novel Nonnucleoside Reverse Transcriptase Inhibitor GW420867X Is Unaffected by Food in Healthy Male Volunteers The Journal of Clinical Pharmacology ·Lindsey Cass,Katy H. P. Moore,Nigel Dallow,Anne E. Jones,Jonathan R. Sisson,William Prince	2001	23
11	GW420867X Administered to HIV-1-Infected Patients Alone and in Combination with Lamivudine and Zidovudine HIV Clinical Trials ·Keikawus Arastéh,Robin Wood,Markus Müller,William Prince,Lindsey Cass,Katy H. P. Moore,Nigel Dallow,Anne E. Jones,Astrid Klein,Vikki Burt,Jőrg‐Peter Kleim	2001	11
12	Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor European Journal of Clinical Pharmacology ·Katy H. P. Moore,Lindsey Cass,Nigel Dallow,Timothy C. Hardman,Adam Jones,Malcolm Boyce,William Prince	2001	7
13	Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir Respiratory Medicine ·Lindsey Cass,Kulasiri A. Gunawardena,Mark MacMahon,Alan Bye	2000	33
14	Brain and CSF entry of the novel nonnucleoside reverse transcriptase inhibitor, GW420867X Neuroreport ·Sarah Thomas,Lindsey Cass,William Prince,M. B. Segal	2000	3
15	Nasal Cytokine and Chemokine Responses in Experimental Influenza A Virus Infection: Results of a Placebo‐Controlled Trial of Intravenous Zanamivir Treatment The Journal of Infectious Diseases ·Richard Fritz,Frederick G. Hayden,David P. Calfee,Lindsey Cass,Amy Peng,W. Gregory Alvord,Warren Strober,Stephen E. Straus	1999	170
16	Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers Clinical Pharmacokinetics ·Lindsey Cass,Constantin Efthymiopoulos,Alan Bye	1999	162
17	Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy Volunteers Clinical Pharmacokinetics ·Lindsey Cass,Joanne Brown,Matthew Pickford,Susan T. Fayinka,Stephen P. Newman,Carl J. Johansson,Alan Bye	1999	101
18	Effect of Renal Impairment on the Pharmacokinetics of Intravenous Zanamivir Clinical Pharmacokinetics ·Lindsey Cass,Constantin Efthymiopoulos,Julie Marsh,Alan Bye	1999	21
19	Deposition and Disposition of [C]Zanamivir Following Administration as an Intranasal Spray Clinical Pharmacokinetics ·Mats Bergström,Lindsey Cass,Sven Valind,Göran Westerberg,Eva-Lise Lundberg,Steven Gray,Alan Bye,Bengt Långström	1999	50
20	A Unique Association of Two Species of Lepidoptera The Canadian Entomologist ·Lindsey Cass	1957	1

About Lindsey Cass

Lindsey Cass is a scholar working on Virology, Infectious Diseases and Insect Science, having authored 37 papers that have together received 1.0k indexed citations. Recurring topics across this work include Respiratory viral infections research (11 papers), Asthma and respiratory diseases (6 papers), HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers), Antifungal resistance and susceptibility (5 papers), Insect-Plant Interactions and Control (5 papers), Influenza Virus Research Studies (4 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Epidemiology (670 citations), Infectious Diseases (289 citations) and Physiology (32 citations). Lindsey Cass has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Alan Bye, Constantin Efthymiopoulos, Amy Peng, Frederick G. Hayden, David P. Calfee, D. G. Harcourt, Richard Fritz, W. Gregory Alvord, Warren Strober and Stephen E. Straus. Their work appears in journals such as Nature, American Journal of Respiratory and Critical Care Medicine and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact